Furthermore, in a small subset of 10 patients with HCC who were receiving anti-PD-1 antibodies, the presence of PD-L1+ CTCs was predominantly observed in patients with locally advanced or metastatic disease and independently prognosticated OS (97). Here, CD274 is linked to hepatocellular carcinoma.